Formulation and evaluation of taste masked Amlodipine Besylate Fast-dissolving Sublingual Tablets

Ashok Thulluru, K. Venkatesh, Et Sarath Chowdhary, Sravanti Kakarla
{"title":"Formulation and evaluation of taste masked Amlodipine Besylate Fast-dissolving Sublingual Tablets","authors":"Ashok Thulluru, K. Venkatesh, Et Sarath Chowdhary, Sravanti Kakarla","doi":"10.21276/IJRDPL.2278-0238.2017.6(6).2824-2832","DOIUrl":null,"url":null,"abstract":"http://dx.doi.org/10.21276/IJRDPL.227 8-0238.2017.6(6).2824-2832 ABSTRACT: Aim: In the present study was to taste mask the Amlodipine Besylate (AML) by forming complex with Eudragit EPO by and further to enhance the dissolution rate AML by formulating these drug polymer complex (DPC) into fast dissolving sublingual tablet (SLT) by direct compression technique. Objectives: To prepare DPC by hot melt extrusion method. Physico-chemical characterization of DPC by FT-IR, DSC and XRD studies. To check the superiority of selected superdisintegrants [sodium starch glycolate (SSG), croscarmellose sodium (CCS), crosspovidone (CPV) and sodium carboxymethyl cellulose (SCMC)] in enhancing the dissolution rate of AML from its SLT. To fasten the onset of action, to decrease the hepatic metabolism and thereby increasing AML’s bioavailability in comparison to its conventional tablets. Methods: Standard calibration curve of AML in pH 6.8 phosphate buffer was constructed by spectrophotometric method, drug-excipient compatibility was checked by FT-IR studies. All the Formulations were evaluated for pre& post-compression studies. Accelerated stability studies up to 3 months were conducted for the optimized formulation in a HDPE container pack, as per ICH guidelines. Results and Discussions: Superdisintegrants used in the study are compatible with AML. Pre& postcompression parameters were within the acceptable limits for all formulations. In vitro dissolution kinetic studies indicate the release of AML from SLT increases with the increased concentration of superdisintegrants. The order of superdisintegrants in enhancing the dissolution rate of AML is CPV > SCMC > CCS > SSG. Formulation F3 with 8% w/w CPV, had the highest dissolution efficiency at 10 min (DE10 = 49.80 %); first order dissolution rate constant (K1 = 0.198 min ) with a regression coefficient (r = 0. 956) and lesser time for 50% of drug release (t50 < 6 min), which shows min wetting time of 21.12 sec and min disintegration time of 17 sec, was considered as the optimal SLT. It passed the test for stability as per ICH guidelines. Conclusion: An optimized taste masked AML SLT with the taste masked DPC in combination with the addition of artificial flavor and sweetener was formulated by the direct compression technique, with 8% w/w CPV as superdisintegrant, which will fasten the onset of action and enhances the bioavailability of AML in comparison to its conventional tablets. ⇑ Corresponding author at: Ashok Thulluru, Asstt. Prof., Sree Vidyanikethan College of Pharmacy, A. Rangampet, Tirupati-517102, Chittoor Dist., AP India E-mail address: ashokthulluru@gmail.com","PeriodicalId":14206,"journal":{"name":"International Journal of Research and Development in Pharmacy and Life Sciences","volume":"5 1","pages":"2824-2832"},"PeriodicalIF":0.0000,"publicationDate":"2017-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Research and Development in Pharmacy and Life Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21276/IJRDPL.2278-0238.2017.6(6).2824-2832","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

http://dx.doi.org/10.21276/IJRDPL.227 8-0238.2017.6(6).2824-2832 ABSTRACT: Aim: In the present study was to taste mask the Amlodipine Besylate (AML) by forming complex with Eudragit EPO by and further to enhance the dissolution rate AML by formulating these drug polymer complex (DPC) into fast dissolving sublingual tablet (SLT) by direct compression technique. Objectives: To prepare DPC by hot melt extrusion method. Physico-chemical characterization of DPC by FT-IR, DSC and XRD studies. To check the superiority of selected superdisintegrants [sodium starch glycolate (SSG), croscarmellose sodium (CCS), crosspovidone (CPV) and sodium carboxymethyl cellulose (SCMC)] in enhancing the dissolution rate of AML from its SLT. To fasten the onset of action, to decrease the hepatic metabolism and thereby increasing AML’s bioavailability in comparison to its conventional tablets. Methods: Standard calibration curve of AML in pH 6.8 phosphate buffer was constructed by spectrophotometric method, drug-excipient compatibility was checked by FT-IR studies. All the Formulations were evaluated for pre& post-compression studies. Accelerated stability studies up to 3 months were conducted for the optimized formulation in a HDPE container pack, as per ICH guidelines. Results and Discussions: Superdisintegrants used in the study are compatible with AML. Pre& postcompression parameters were within the acceptable limits for all formulations. In vitro dissolution kinetic studies indicate the release of AML from SLT increases with the increased concentration of superdisintegrants. The order of superdisintegrants in enhancing the dissolution rate of AML is CPV > SCMC > CCS > SSG. Formulation F3 with 8% w/w CPV, had the highest dissolution efficiency at 10 min (DE10 = 49.80 %); first order dissolution rate constant (K1 = 0.198 min ) with a regression coefficient (r = 0. 956) and lesser time for 50% of drug release (t50 < 6 min), which shows min wetting time of 21.12 sec and min disintegration time of 17 sec, was considered as the optimal SLT. It passed the test for stability as per ICH guidelines. Conclusion: An optimized taste masked AML SLT with the taste masked DPC in combination with the addition of artificial flavor and sweetener was formulated by the direct compression technique, with 8% w/w CPV as superdisintegrant, which will fasten the onset of action and enhances the bioavailability of AML in comparison to its conventional tablets. ⇑ Corresponding author at: Ashok Thulluru, Asstt. Prof., Sree Vidyanikethan College of Pharmacy, A. Rangampet, Tirupati-517102, Chittoor Dist., AP India E-mail address: ashokthulluru@gmail.com
掩味苯磺酸氨氯地平速溶舌下片的研制及评价
http://dx.doi.org/10.21276/IJRDPL.227 8-0238.2017.6(6)。摘要:目的:通过与尤德拉吉特EPO形成络合物对苯磺酸氨氯地平(Amlodipine Besylate, AML)进行复配,并采用直接压片法将这些药物聚合物络合物(DPC)制成速溶舌下片(SLT),进一步提高AML的溶出率。目的:采用热熔挤压法制备DPC。用FT-IR、DSC和XRD研究了DPC的理化性质。考察所选超崩解剂[淀粉乙醇酸钠(SSG)、交联棉糖钠(CCS)、交联维酮(CPV)和羧甲基纤维素钠(SCMC)]在提高AML的SLT溶出率方面的优势。为了加快作用的开始,减少肝脏代谢,从而提高AML的生物利用度与传统片剂相比。方法:采用分光光度法建立AML在pH 6.8磷酸盐缓冲液中的标准校准曲线,采用傅里叶红外(FT-IR)研究药物与赋形剂的配伍性。所有的配方在压缩前和压缩后都进行了评估。根据ICH指南,在HDPE容器包装中对优化后的配方进行了长达3个月的加速稳定性研究。结果和讨论:研究中使用的超级崩解剂与AML兼容。压缩前后参数均在所有配方的可接受范围内。体外溶出动力学研究表明,AML的释放随着超崩解剂浓度的增加而增加。超崩解剂提高AML溶出率的顺序为CPV > SCMC > CCS > SSG。配方F3在CPV为8%时,10 min溶出效率最高(DE10 = 49.80%);一级溶出速率常数K1 = 0.198 min,回归系数r = 0。956)和更短的50%药物释放时间(t50 < 6 min),最小润湿时间为21.12秒,最小崩解时间为17秒,被认为是最佳的SLT。它通过了ICH指导方针的稳定性测试。结论:采用直接压缩技术,以8% w/w的CPV作为超崩解剂,制备了以DPC为复合添加剂,添加人工香精和甜味剂的掩味AML SLT,与常规AML片剂相比,能加快AML的起效时间,提高其生物利用度。作者:Ashok Thulluru, assist。Sree Vidyanikethan药学院教授,A. Rangampet, Tirupati-517102,美联社印度Chittoor区。电子邮件地址:ashokthulluru@gmail.com
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信